Welcome to CSNpharm! For Research Use Only!
Home
+1-708-781-1677
sales@csnpharm.com
p38 MAPK
| Cat. No. | Product Name | CAS No. | Information |
|---|---|---|---|
| CSN16728 | VX-745 | 209410-46-8 | VX-745 is a potent and selective inhibitor of p38 with IC50 of 10 nM, 22-fold greater selectivity versus p38 and no inhibition to p38. |
| CSN16018 | VX-702 | 745833-23-2 | VX-702 is a highly selective inhibitor of p38 MAPK with IC50 of 4 -20 nM. |
| CSN15958 | TAK-715 | 303162-79-0 | TAK-715 is a p38 MAPK inhibitor for p38 with IC50 of 7.1 nM, being 28-fold selective for p38 over p38, showing no inhibition to p38, JNK1, ERK1, IKK, MEKK1 or TAK1. |
| CSN18029 | TA-02 | 1784751-19-4 | TA-02 is a p38 MAPK inhibitor with IC50 of 20 nM |
| CSN13149 | SKF-86002 | 72873-74-6 | SKF-86002 is a potent inhibitor of p38 MAP kinase with IC50 of 0.5-1 M and inhibits LPS-induced IL-1 and TNF- production in human monocytes (IC50 1 M). |
| CSN17172 | Skepinone-L | 1221485-83-1 | Skepinone-L is a selective p38 mitogen-activated protein kinase inhibitor. |
| CSN18176 | SD-06 | 271576-80-8 | SD-06 is a p38 MAP kinase inhibitor and inhibits p38 with an IC50 value of 170 nM and inhibits LPS-stimulated TNF-release in rats(83 inhibition at 1mgkg, po). |
| CSN16503 | Scopoletin | 92-61-5 | Scopoletin has important anti-inflammatory activity by inhibiting the phosphorylation of NF-B and p38 MAPK. |
| CSN18198 | SCIO-469 | 309913-83-5 | SCIO-469 is a selective ATP-competitive p38 inhibitor with IC50 of 9 nM for p38α in vitro, about 10-fold selectivity for p38α over p38β, and at least 2000-fold selectivity for p38α over an in vitro panel of 20 other kinases, including other MAK kinases. |
| CSN13746 | SB-242235 | 193746-75-7 | SB-242235 is a potent and selective p38 MAP kinase inhibitor with IC50 of 10 M |
| CSN11899 | SB-203580 | 152121-47-6 | SB-203580 is a p38 MAPK inhibitor with IC50 of 0.3-0.5 M. |
| CSN18506 | SB-203580 HCl | 869185-85-3 | SB-203580 hydrochloride is a p38 MAPK inhibitor with IC50 of 03-05 M |
| CSN12267 | SB-202190 | 152121-30-7 | SB-202190 is a highly selective potent and cell-permeable inhibitor of p38 MAP kinase with IC50 values of 50 nM and 100 nM for p38 and p38 respectively also shows slightly weaker activity for BRD4 Kd34 M |
| CSN12897 | SB-239063 | 193551-21-2 | SB 239063 is a potent, selective and oral active p38 MAPK inhibitor with IC50 of 44 nM for recombinant purified p38. |
| CSN18788 | R1487 HCl | 449808-64-4 | R1487 hydrochloride is highly potent and highly selective inhibitors of p38 |
| CSN13463 | PH-797804 | 586379-66-0 | PH-797804 is a pyridinone inhibitor of p38 with IC50 of 26 nM, being 4-fold selective versus p38 and does not inhibit JNK2. |
| CSN19212 | Pexmetinib | 945614-12-0 | Pexmetinib is a potent, orally bioavailable, dual p38 MAPKTie-2 inhibitor with IC50 of 4 nM18 nM in a HEK-293 cell line. |
| CSN13817 | PD169316 | 152121-53-4 | PD169316 is a potent, cell-permeable and selective p38 MAP kinase inhibitor (IC50 89 nM). |
| CSN19013 | Pamapimod | 449811-01-2 | Pamapimod is a selective inhibitor of p38 mitogen-activated protein kinase. It inhibits p38 and p38 enzymatic activity with IC50 values of 0.0140.002 and 0.48 0.04 mM, respectively with no activity against p38delta or p38gamma isoforms. |
| CSN17386 | p38 MAPK-IN-1 | 1006378-90-0 | p38 MAPK-IN-1 is a potent and selective inhibitor of p38 MAPK with IC50 of 68 nM shows sustained levels low clearance and good bioavailability |
| CSN20238 | NJK14047 | 1800576-41-3 | NJK14047 is a selective biphenyl amide p38 MAPK inhibitor which can be used in anti-viral approach targeting hepatitis B virus |
| CSN22457 | MAPK13-IN-1 | 229002-10-2 | MPAK13-IN-1 is a MAPK13 p38 inhibitor with an IC50 of 620 nM |
| CSN16041 | LY2228820 | 862507-23-1 | LY2228820 is a potent p38MAPK inhibitor with IC50 of 7 nM and 3 nM for p38MAPK and p38MAPK. |
| CSN18346 | Losmapimod | 585543-15-3 | Losmapimod is a selective, potent, and orally active p38 MAPK inhibitor with pKi of 8.1 and 7.6 for p38 and p38, respectively. |
| CSN22233 | ITX5061 | 1252679-52-9 | ITX5061 is a type II inhibitor of p38 MAPK and also an antagonist of scavenger receptor B1 SR-B1 |
| CSN22404 | FR 167653 | 158876-66-5 | FR-167653 is a selective p38 MAPK inhibitor |
| CSN22405 | FR 167653 Free Base | 158876-65-4 | FR-167653 is a selective p38 MAPK inhibitor |
| CSN10856 | Doramapimod | 285983-48-4 | Doramapimod is a highly selective p38 MAPK inhibitor with Kd of 0.1 nM, 330-fold greater selectivity versus JNK2, weak inhibition for c-RAF, Fyn and Lck, insignificant inhibition of ERK-1, SYK, IKK2, ZAP-70, EGFR, HER2, PKA, PKC, PKC. |
| CSN19850 | Deoxynivalenol | 51481-10-8 | Deoxynivalenol is a tricothecene mycotoxin and potent protein synthesis inhibitor |
| CSN19015 | Dehydrocorydaline Chloride | 10605-03-5 | Dehydrocorydaline chloride is an alkaloidal that has anti-inflammatory and anti-cancer activities |
| CSN20299 | CBS-3595 | 452056-93-8 | CBS-3595 is a dual p38 MAPKPDE-4 inhibitor with activity against TNF -related diseases. |
| CSN18737 | BMS-582949 | 623152-17-0 | BMS-582949 is a potent and selective p38 mitogen-activated protein kinase (p38 MAPK) inhibitor with IC50 of 13 nM,inhibiting both p38 kinase activity and activation of p38. |
| CSN18566 | BMS-582949 HCl | 912806-16-7 | BMS-582949 hydrochloride is a highly selective p38 MAPK inhibitor, inhibits p38 with IC50 of 13 nM. |
| CSN22119 | AZD7624 | 1095004-78-6 | AZD7624 is an inhaled p38 inhibitor, with potent anti-inflammatory activity. |
| CSN22609 | AZ304 | 942507-42-8 | AZ304 is an inhibitor of BRAF and can target many kinases The IC50s for wild type BRAF V600E mutant BRAF and wild type CRAF are 79 nM 38 nM and 68 nM respectively It can also inhibit p38 IC50 6 nM and CSF1R IC50 35 nM |
| CSN19014 | Acumapimod | 836683-15-9 | Acumapimod is an orally active p38 MAP kinase inhibitor, with an IC50 of less than 1 M for p38. |
+1-708-781-1677
+1-708-286-6026
sales@csnpharm.com
